Literature DB >> 3258793

Effects of phenytoin on cell-mediated immunity.

Y Okamoto1, K Shimizu, K Tamura, Y Miyao, M Yamada, N Tsuda, Y Matsui, H Mogami.   

Abstract

The effects of phenytoin on cellular immunity were examined in murine models. Fresh splenocytes were obtained from mice which had received 1 mg/day of phenytoin i.p. for 28 days. The serum concentration of phenytoin in these animals was 10-20 micrograms/ml. The proliferative response of splenocytes to mitogens was assessed by 3H-thymidine incorporation. The cytotoxic activities of cells such as natural killer (NK) cells, cytotoxic T lymphocytes (CTL), and lymphokine-activated killer (LAK) cells were estimated by a 4-h 51Cr release assay. The 3H-thymidine incorporation of splenocytes was reduced significantly (P less than 0.01) in phenytoin-treated mice. The NK and CTL activities of splenocytes from phenytoin-treated mice were significantly suppressed. However, the LAK activity of phenytoin-treated mice was equal to that of control mice.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3258793     DOI: 10.1007/bf00205612

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  22 in total

1.  Enzymatic immunoassay vs. gas/liquid chromatography for determination of phenobarbital and diphenylhydantoin in serum.

Authors:  H E Booker; B A Darcey
Journal:  Clin Chem       Date:  1975-11       Impact factor: 8.327

2.  Immunologic study of the brain as a privileged site.

Authors:  S Raju; J B Grogan
Journal:  Transplant Proc       Date:  1977-03       Impact factor: 1.066

3.  [The anti-tumor efficacy of lymphokine-activated killer (LAK) cells induced in vitro from peripheral blood lymphocytes of patients with malignant glioma].

Authors:  K Shimizu; Y Miyao; Y Okamoto; Y Matsui; Y Ushio; N Tsuda; T Hayakawa; N Ishida; H Mogami
Journal:  No To Shinkei       Date:  1986-03

4.  Depression of immune competence by phenytoin and carbamazepine. Studies in vivo and in vitro.

Authors:  T C Sorrell; I J Forbes
Journal:  Clin Exp Immunol       Date:  1975-05       Impact factor: 4.330

5.  Selective diphenylhydantoin-induced suppression of lymphocyte reactivity in vitro.

Authors:  A Bluming; S Homer; R Khiroya
Journal:  J Lab Clin Med       Date:  1976-09

6.  Expression of HLA-DR and common acute lymphoblastic leukemia antigens on glioma cells.

Authors:  S Carrel; N De Tribolet; N Gross
Journal:  Eur J Immunol       Date:  1982-04       Impact factor: 5.532

7.  Immunobiology of primary intracranial tumours. III. Demonstration of a qualitative lymphocyte abnormality in patients with primary brain tumours.

Authors:  T L Roszman; W H Brooks
Journal:  Clin Exp Immunol       Date:  1980-02       Impact factor: 4.330

8.  Immunological abnormalities and hydantoins.

Authors:  P J Grob; G E Herold
Journal:  Br Med J       Date:  1972-06-03

9.  The effect of phenytoin in vitro on normal human mononuclear cells and on human lymphoblastoid B cell lines of different Ig isotype specificities.

Authors:  A G Wangel; H Arvilommi; I Jokinen
Journal:  Immunobiology       Date:  1985-09       Impact factor: 3.144

10.  Secondary cell-mediated lympholysis: importance of H-2 LD and SD factors.

Authors:  B J Alter; C Grillot-Courvalin; M L Bach; K S Zier; P M Sondel; F H Bach
Journal:  J Exp Med       Date:  1976-05-01       Impact factor: 14.307

View more
  5 in total

1.  Phenytoin promotes Th2 type immune response in mice.

Authors:  K Okada; T Sugiura; E Kuroda; S Tsuji; U Yamashita
Journal:  Clin Exp Immunol       Date:  2001-06       Impact factor: 4.330

2.  Interleukin 2 receptor beta chain expressed in an oligodendroglioma line binds interleukin 2 and delivers growth signal.

Authors:  Y Okamoto; S Minamoto; K Shimizu; H Mogami; T Taniguchi
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

3.  Anticonvulsant-induced suppression of IFN-gamma production by lymphocytes obtained from cervical lymph nodes in glioma-bearing mice.

Authors:  M Yamada; M Ohkawa; K Tamura; E Mabuchi; H Kishima; M Tamura; K Shimizu
Journal:  J Neurooncol       Date:  2000-04       Impact factor: 4.130

4.  Phenytoin as a novel anti-vitiligo weapon.

Authors:  M R Namazi
Journal:  J Autoimmune Dis       Date:  2005-11-22

Review 5.  Voltage-gated sodium channel as a target for metastatic risk reduction with re-purposed drugs.

Authors:  Tomas Koltai
Journal:  F1000Res       Date:  2015-07-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.